New 13D19
New 13G91
Stated intents0
The week of 2026-04-20, 19 holders filed a new Schedule 13D and 91 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-20 | Lincoln Partners Group Royalty Fund | Lincoln National Corporation | 80.94% | SCHEDULE 13D |
| 2026-04-20 | Lincoln Bain Capital Total Credit Fund | Lincoln National Corporation | 62.57% | SCHEDULE 13D |
| 2026-04-24 | Jyong Biotech Ltd. | Perfect Minds Co., Ltd | 33.34% | SCHEDULE 13D |
| 2026-04-23 | Kailera Therapeutics, Inc. | BCPE Perseus Investor, LP | 20.27% | SCHEDULE 13D |
| 2026-04-20 | Reliability Inc | Jeffrey E. Eberwein | 19% | SCHEDULE 13D |
| 2026-04-23 | Kailera Therapeutics, Inc. | BCLS Fund IV Investments, L.P. | 17.43% | SCHEDULE 13D |
| 2026-04-24 | SMX (Security Matters) Public Limited Company | Haggai Alon | 16.24% | SCHEDULE 13D |
| 2026-04-24 | Achieve Life Sciences, Inc. | Tpg Gp A, LLC | 12.6% | SCHEDULE 13D |
| 2026-04-22 | Pulmatrix, Inc. | RCM Eos PIPE HOLDINGS, LLC | 9.99% | SCHEDULE 13D |
| 2026-04-23 | Alamar Biosciences, Inc. | Illumina Innovation Fund II, L.P. | 9.6% | SCHEDULE 13D |
| 2026-04-21 | ImageneBio, Inc. | Omega Fund VI, L.P. | 8.4% | SCHEDULE 13D |
| 2026-04-20 | Antalpha Platform Holding Co | Tether Global Investments Fund, S.I.C.A.F., S.A. | 8.2% | SCHEDULE 13D |
| 2026-04-20 | Ionetix Corp / DE / | Shamrock Ionetix LLC | 7.2% | SCHEDULE 13D |
| 2026-04-22 | Reliability Inc | Mark R. Speck | 7.01% | SCHEDULE 13D |
| 2026-04-23 | Alamar Biosciences, Inc. | Sands Capital Life Sciences Pulse Fund II, L.P. | 6.3% | SCHEDULE 13D |
| 2026-04-20 | Silicom Ltd | Eizenman Avinoam | 5.7% | SCHEDULE 13D |
| 2026-04-24 | InspireMD, Inc. | Marvin Slosman | 5.18% | SCHEDULE 13D |
| 2026-04-24 | Mannatech Inc | Toth Robert | 5.1% | SCHEDULE 13D |
| 2026-04-22 | Truworths International Ltd | Standard Bank Of South Africa Ltd | 5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-22 | BTQ Technologies Corp. | Olivier Roussy Newton | 30.4% | SCHEDULE 13G |
| 2026-04-20 | Rank One Computing Corp | Brendan Klare | 25.3% | SCHEDULE 13G |
| 2026-04-20 | Rank One Computing Corp | Joshua Klontz | 25.3% | SCHEDULE 13G |
| 2026-04-24 | Guardian Metal Resources PLC | UCAM Limited | 24.4% | SCHEDULE 13G |
| 2026-04-20 | Ionetix Corp / DE / | Ospraie Real Assets Fund LP | 19.9% | SCHEDULE 13G |
| 2026-04-20 | Rank One Computing Corp | Scott Klum | 16.8% | SCHEDULE 13G |
| 2026-04-23 | Cyabra, Inc. | Trailblazer Sponsor Group, LLC | 15.6% | SCHEDULE 13G |
| 2026-04-23 | LEE ENTERPRISES, Inc | Quint Digital Ltd | 14.6% | SCHEDULE 13G |
| 2026-04-23 | AGI Inc | Lumina Capital Management Ltda. | 13.7% | SCHEDULE 13G |
| 2026-04-20 | Lucid Group, Inc. | Uber Technologies, Inc | 11.52% | SCHEDULE 13G |
| 2026-04-22 | Abits Group Inc | Empery Asset Management, LP | 9.99% | SCHEDULE 13G |
| 2026-04-22 | Cyngn Inc. | Empery Asset Management, LP | 9.99% | SCHEDULE 13G |
| 2026-04-22 | Momentus Inc. | Kenneth Griffin | 9.99% | SCHEDULE 13G |
| 2026-04-24 | Curis, Inc. | Nantahala Capital Management, LLC | 9.99% | SCHEDULE 13G |
| 2026-04-20 | TransCode Therapeutics, Inc. | YA II PN, Ltd. | 9.9% | SCHEDULE 13G |
| 2026-04-21 | ImageneBio, Inc. | Trails Edge Capital Partners, LP | 9.9% | SCHEDULE 13G |
| 2026-04-23 | zSpace, Inc. | 3i, LP | 9.9% | SCHEDULE 13G |
| 2026-04-23 | Capstone Holding Corp. | 3i, LP | 9.9% | SCHEDULE 13G |
| 2026-04-20 | Hartford Funds Exchange-Traded Trust | Truist Financial Corp | 9.3% | SCHEDULE 13G |
| 2026-04-24 | Achieve Life Sciences, Inc. | Paradigm BioCapital Advisors LP | 9.2% | SCHEDULE 13G |
| 2026-04-22 | First Tracks Biotherapeutics, Inc. | EcoR1 Capital, LLC | 9.1% | SCHEDULE 13G |
| 2026-04-22 | Franklin Covey Co | Royce & Associates LP | 9.03% | SCHEDULE 13G |
| 2026-04-24 | MKDWELL Tech Inc. | Lu Huang | 8.8% | SCHEDULE 13G |
| 2026-04-20 | ETF Opportunities Trust | Truist Financial Corp | 8.6% | SCHEDULE 13G |
| 2026-04-23 | 1606 Corp. | Greg Paul Lambrecht | 8.6% | SCHEDULE 13G |
| 2026-04-22 | OSR Health, Inc. | joint protein central inc. | 7.9% | SCHEDULE 13G |
| 2026-04-24 | Soundthinking, Inc. | Kopion Asset Management, LLC | 7.9% | SCHEDULE 13G |
| 2026-04-20 | Rank One Computing Corp | Benjamin Klein | 7.8% | SCHEDULE 13G |
| 2026-04-23 | Applied Energetics, Inc. | Ingalls & Snyder LLC | 7.7% | SCHEDULE 13G |
| 2026-04-24 | Liveone Inc | Broadcast Music, LLC | 7.6% | SCHEDULE 13G |
| 2026-04-21 | NeuroOne Medical Technologies Corporation | Brian Pratt | 7.4% | SCHEDULE 13G |
| 2026-04-22 | Pasithea Therapeutics Corp. | Funicular Funds, LP | 7.4% | SCHEDULE 13G |
| 2026-04-21 | Nicola Mining Inc. | Kenneth Griffin | 7.2% | SCHEDULE 13G |
| 2026-04-21 | Hurco Companies Inc | Carl K. Oppenheimer | 7.14% | SCHEDULE 13G |
| 2026-04-23 | Avnet Inc | Pzena Investment Management LLC | 7.1% | SCHEDULE 13G |
| 2026-04-22 | Micropolis AI Robotics | Fares Mohd Said Mustafa Abubaker | 6.75% | SCHEDULE 13G |
| 2026-04-21 | Lyell Immunopharma, Inc. | Euler Fund, L.P. | 6.71% | SCHEDULE 13G |
| 2026-04-20 | First Trust Exchange-Traded Fund VI | Truist Financial Corp | 6.7% | SCHEDULE 13G |
| 2026-04-20 | Rank One Computing Corp | B. Scott Swann | 6.7% | SCHEDULE 13G |
| 2026-04-22 | Transcat, Inc. | Royce & Associates LP | 6.58% | SCHEDULE 13G |
| 2026-04-22 | BRC Group Holdings, Inc. | Daniel Asher | 6.54% | SCHEDULE 13G |
| 2026-04-24 | Achieve Life Sciences, Inc. | Frazier Life Sciences Public Fund, L.P. | 6.5% | SCHEDULE 13G |
| 2026-04-24 | JATT II Acquisition Corp. | Great Point Partners, LLC | 6.41% | SCHEDULE 13G |
| 2026-04-21 | The Vita Coco Company, Inc. | Wasatch Advisors LP | 6.4% | SCHEDULE 13G |
| 2026-04-24 | JATT II Acquisition Corp. | Commodore Capital LP | 6.4% | SCHEDULE 13G |
| 2026-04-20 | SPACSphere Acquisition Corp. | Wolverine Asset Management, LLC | 6.39% | SCHEDULE 13G |
| 2026-04-20 | Zacks Trust | Truist Financial Corp | 6.2% | SCHEDULE 13G |
| 2026-04-22 | CI&T Inc | Royce & Associates LP | 6.2% | SCHEDULE 13G |
| 2026-04-22 | Enhanced Group Inc. | Harraden Circle Investments, LLC | 6.17% | SCHEDULE 13G |
| 2026-04-20 | Golar Lng Ltd | TOMS Capital Investment Management LP | 6.1% | SCHEDULE 13G |
| 2026-04-22 | Esperion Therapeutics, Inc. | Wasatch Advisors LP | 6.1% | SCHEDULE 13G |
| 2026-04-22 | American Integrity Insurance Group, Inc. | Wasatch Advisors LP | 6.1% | SCHEDULE 13G |
| 2026-04-21 | Diana Shipping Inc. | F. Laeisz GmbH | 6% | SCHEDULE 13G |
| 2026-04-20 | Newbridge Acquisition Limited | Wolverine Asset Management, LLC | 5.97% | SCHEDULE 13G |
| 2026-04-21 | Everus Construction Group Inc | Wasatch Advisors LP | 5.9% | SCHEDULE 13G |
| 2026-04-20 | Staar Surgical Co | Madison Avenue International LP | 5.8% | SCHEDULE 13G |
| 2026-04-24 | QuasarEdge Acquisition Corp | Harraden Circle Investments, LLC | 5.78% | SCHEDULE 13G |
| 2026-04-22 | Diamond Hill Investment Group | Glazer Capital, LLC | 5.75% | SCHEDULE 13G |
| 2026-04-22 | Optex Systems Holdings Inc | Wasatch Advisors LP | 5.7% | SCHEDULE 13G |
| 2026-04-20 | Andretti Acquisition Corp. II | Wolverine Asset Management, LLC | 5.66% | SCHEDULE 13G |
| 2026-04-22 | HiTek Global Inc. | China Legends management Consultancy Limited | 5.64% | SCHEDULE 13G |
| 2026-04-20 | Blueport Acquisition Ltd | Wolverine Asset Management, LLC | 5.61% | SCHEDULE 13G |
| 2026-04-21 | Barrett Business Services Inc | Royce & Associates LP | 5.45% | SCHEDULE 13G |
| 2026-04-22 | Hingham Institution for Savings | Royce & Associates LP | 5.42% | SCHEDULE 13G |
| 2026-04-21 | Sutro Biopharma, Inc. | Perceptive Advisors LLC | 5.4% | SCHEDULE 13G |
| 2026-04-23 | UFP Technologies Inc | Congress Asset Management Co | 5.4% | SCHEDULE 13G |
| 2026-04-23 | Surrozen, Inc. | Point72 Asset Management, L.P. | 5.4% | SCHEDULE 13G |
| 2026-04-24 | Dave Inc. | Jane Street Group, LLC | 5.4% | SCHEDULE 13G |
| 2026-04-22 | Radiant Logistics, Inc. | Royce & Associates LP | 5.39% | SCHEDULE 13G |
| 2026-04-23 | CSW Industrials Inc | Wasatch Advisors LP | 5.3% | SCHEDULE 13G |
| 2026-04-23 | Palatin Technologies Inc | AuGC BioFund LP | 5.3% | SCHEDULE 13G |
| 2026-04-24 | Safeguard Acquisition Corp. | Linden Advisors LP | 5.3% | SCHEDULE 13G |
| 2026-04-21 | SEACOR Marine Holdings Inc. | Carl K. Oppenheimer | 5.24% | SCHEDULE 13G |
| 2026-04-20 | Datacentrex, Inc. | Eleven Ventures LLC | 5.2% | SCHEDULE 13G |
| 2026-04-22 | Maywood Acquisition Corp. 2 | Whitebox Advisors LLC | 5.2% | SCHEDULE 13G |
| 2026-04-22 | Lennox International Inc | Viking Global Investors LP | 5.2% | SCHEDULE 13G |
| 2026-04-23 | Madison Air Solutions Corporation | Durable Capital Partners LP | 5.2% | SCHEDULE 13G |
| 2026-04-24 | Achieve Life Sciences, Inc. | Venrock Healthcare Capital Partners III, L.P. | 5.2% | SCHEDULE 13G |
| 2026-04-20 | Solarius Capital Acquisition Corporation | Wolverine Asset Management, LLC | 5.18% | SCHEDULE 13G |
| 2026-04-20 | Miluna Acquisition Corp | Wolverine Asset Management, LLC | 5.15% | SCHEDULE 13G |
| 2026-04-20 | First Trust Exchange-Traded Fund | Truist Financial Corp | 5.1% | SCHEDULE 13G |
| 2026-04-20 | Skinhealth Systems Inc. | Integrated Core Strategies (US) LLC | 5.1% | SCHEDULE 13G |
| 2026-04-20 | GalaxyEdge Acquisition Corp | Wolverine Asset Management, LLC | 5.1% | SCHEDULE 13G |
| 2026-04-22 | Moelis & Co | Wasatch Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-04-23 | PagerDuty Inc | The Goldman Sachs Group, Inc. | 5.1% | SCHEDULE 13G |
| 2026-04-24 | Happen, Inc. | Bay Pond Partners, L.P. | 5.1% | SCHEDULE 13G |
| 2026-04-24 | Happen, Inc. | Bay Pond Investors (Bermuda) L.P. | 5.1% | SCHEDULE 13G |
| 2026-04-20 | Lion Copper & Gold Corp. | Truist Financial Corp | 5% | SCHEDULE 13G |
| 2026-04-20 | Morgan Stanley India Investment Fund, Inc. | Gates Foundation Trust | 5% | SCHEDULE 13G |
| 2026-04-22 | Spyre Therapeutics, Inc. | Perceptive Advisors LLC | 5% | SCHEDULE 13G |
| 2026-04-23 | Spirit Aviation Holdings, Inc | Galkin Vladimir | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)110 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.